City of Hope
City of Hope, TGen Win $4.5M Grant to Advance Pancreatic Cancer Liquid Biopsy Screening
A City of Hope-led consortium aims to validate a noninvasive screening test for pancreatic ductal adenocarcinoma in a large-scale, diverse cohort.
People in the News at BioMérieux, City of Hope, Ultima Genomics, NeoGenomics, Burning Rock, More
Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of June 26, 2023
Texas Research Institute, TGen, OncoHost Partner to ID Lung Cancer Resistance Mechanisms
Collaborators will study the immune profiles and molecular features of NSCLC to better understand patterns of response and resistance to immunotherapy.
Natera Minimal Residual Disease Test Value Called Into Question by City of Hope CRC Patient Data
Based on the results of their new study, City of Hope researchers advised doctors against overreliance on Natera's Signatera assays for recurrence monitoring.
Aiming to Cut Unnecessary Surgeries, City of Hope Team to Commercialize CRC Metastasis Dx Signature
Premium
The team will use the reverse-transcriptase quantitative PCR test, which uses a milliliter of a patient's blood, to curb unneeded radical colon cancer surgeries.
Mar 1, 2021
May 29, 2020
Aug 27, 2019
NHGRI Awards $3M Under Genomic Innovator Program
Aug 9, 2019
Jul 24, 2012
Apr 4, 2012
Oct 4, 2011